UK-based subsidiary Jaguar Land Rover (JLR) reported a sharp decline in second-quarter sales, hit by a cyber incident and the ...

Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...

In recent months, the refreshed Tesla Model Y has also been seeing an uptick in sales, with September making it the ...

Neurizon Therapeutics is free to advance the next clinical trial of its candidate to treat amyotrophic lateral sclerosis (ALS ...

Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...

Market expert Ankush Bajaj recommends three PSU bank stocks to buy on 6 October. Discover his exclusive picks and analysis to ...

Skoda Group has launched the first four-car metro train for Sofia, the capital of Bulgaria, at its manufacturing site in ...

Top-five days from Kyle Larson and Christopher Bell moved the postseason needle as four drivers were eliminated from the Cup Series Playoffs.

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its phase 3 ...

It's called the Ferrari Elettrica. And it's not just an EV of an existing Ferrari, but a whole new approach to extreme ...

Crude oil futures drop as Trump announces peace plan for Israel-Hamas conflict, easing West Asia tensions and reducing war ...